Otolaryngology · Houston, TX
NPI
1255540175
Since 2007
Specialty
Otolaryngology
Code 207Y00000X
Group practices
2
Medicare group memberships
Hospitals
2
Hospital affiliations
18300 Katy Fwy Ste 605
Houston, TX, 77094
Phone (281) 578-1910
Groups this clinician bills Medicare through
Medicare paid, 2024
$101K
907 services
Medicare patients, 2024
223
Average age 74
Drug cost, 2024
$194K
1,119 prescriptions
Company payments, 2025
$1,281
From 15 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Karen A Bednarski was code 99214 (office e&m - established), 307 times for 164 patients. In total Karen A Bednarski billed 907 services in 46 codes, and Medicare paid $101K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2026-01-27.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99214 Office E&M - Established | Office | 307 | 164 | $94.81 | $29K |
| 31231 Nasal/Sinus Endoscopy | Office | 133 | 66 | $138.54 | $18K |
| G2211 Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's | Office | 96 | 84 | $12.58 | $1,207 |
| 99213 Office E&M - Established | Office | 63 | 54 | $68.14 | $4,293 |
| 99204 Office E&M - New | Office | 60 | 60 | $120.63 | $7,238 |
| 70486 CT/CTA - Head and Neck | Office | 41 | 37 | $95.38 | $3,911 |
| 69210 Other Organ Systems | Office | 26 | 20 | $33.38 | $868 |
| 92557 Vision, Hearing, and Speech Services | Office | 23 | 21 | $27.92 | $642 |
| 31575 Other Organ Systems | Office | 19 | 15 | $97.87 | $1,860 |
| 31237 Nasal/Sinus Endoscopy | Office | 17 | 13 | $249.25 | $4,237 |
| 92567 Test - Miscellaneous | Office | 16 | 15 | $12.93 | $207 |
By year: 2022 $87K for 819 services; 2023 $92K for 841 services; 2024 $101K for 907 services.
Medicare prescription drug claims, 2024
In 2024, the drug Karen A Bednarski prescribed most often to Medicare patients was Fluticasone Propionate, with 168 prescriptions and refills. In total Karen A Bednarski wrote 1,119 Medicare prescriptions that cost $194K.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Fluticasone Propionate Generic | 168 | 349 | 79 | $3,703 |
| Ipratropium Bromide Generic | 154 | 201 | 56 | $5,234 |
| Azelastine Hcl Generic | 127 | 184 | 48 | $3,359 |
| Omeprazole Generic | 59 | 105 | 22 | $773 |
| Doxycycline Hyclate Generic | 50 | 50 | 43 | $648 |
| Mupirocin Generic | 48 | 48 | 31 | $370 |
| Prednisone Generic | 44 | 45 | 35 | $141 |
| Famotidine Generic | 33 | 79 | 18 | $456 |
| Cefdinir Generic | 30 | 30 | 24 | $673 |
| Amoxicillin-Clavulanate Potass Amoxicillin/Potassium Clav | 30 | 30 | 25 | $319 |
| Methylprednisolone Generic | 24 | 24 | 21 | $161 |
| Levocetirizine Dihydrochloride Generic | 24 | 50 | Under 11 | $603 |
| Fluocinolone Acetonide Oil Generic | 22 | 24 | Under 11 | $807 |
| Montelukast Sodium Generic | 19 | 53 | Under 11 | $182 |
| Levofloxacin Generic | 18 | 18 | Under 11 | $102 |
Brand drugs: 76 claims; generic drugs: 1,043 claims; opioid claims: 16.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Karen A Bednarski $1,281 ($1,281 in general payments such as food, travel and fees) from 15 companies. The largest payer was AstraZeneca Pharmaceuticals LP with $219.
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP AZN | 4 | $219 |
| Optinose US, Inc. | 3 | $180 |
| GlaxoSmithKline, LLC. GSK | 8 | $152 |
| Neurent Medical Limited | 1 | $136 |
| CSL Behring CSL.AX | 6 | $117 |
| Regeneron Healthcare Solutions, Inc. REGN | 3 | $74.95 |
| Novartis Pharmaceuticals Corporation NVS | 4 | $73.41 |
| Aerin Medical Inc. | 1 | $65.91 |
| Takeda Pharmaceuticals U.S.A., Inc. TAK | 3 | $62.33 |
| Medtronic, Inc. MDT | 2 | $46.01 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.